Report: Johnson & Johnson wins appeal in $151m hip verdict

Johnson & Johnson (NYSE:JNJ) yesterday won an appeal in a ruling that had previously awarded $151 million to five individuals who claimed they had injuries due to company’s Pinnacle metal-on-metal hip implant, according to a new Reuters report.